Cited by 46Bone health and osteoporosis researchThyroid Cancer Diagnosis and TreatmentThyroid Disorders and Treatments

Influence of Thyroid-stimulating Hormone Suppression Therapy on Bone Mineral Density in Patients with Differentiated Thyroid Cancer: A Meta-analysis

Open access
Yoon, Byung-Ho, Lee, Youjin, Oh, Hyun Jin, Kim, Sung Han, Lee, Young-Kyun·2019·Journal of Bone Metabolism

Abstract

BACKGROUND: The effects of subclinical hyperthyroidism on bone mineral density (BMD) induced by thyroid-stimulating hormone (TSH) suppression therapy in patients with differentiated thyroid cancer (DTC) remains unclear. We conducted a meta-analysis to determine the influence of TSH suppression therapy on BMD. METHODS: We performed a systematic search to identify studies which included BMD measurement of femoral neck, total hip or lumbar spine in patients on TSH suppression therapy for DTC. Main outcome measures were difference of BMD of femoral neck, total hip or lumbar spine measured by dual energy X-ray absorptiometry between patients and controls. RESULTS: <0.001) in postmenopausal women with DTC, while it was not associated with that in premenopausal women and men with DTC. CONCLUSIONS: Although the included studies were limited by small numbers, results suggested possible association between chronic TSH suppression therapy and the lower BMD of spine and total hip in postmenopausal women (but not in premenopausal women and men) with DTC. A large, well-designed study with long-term follow-up would provide further insight into the influence of TSH suppression therapy and loss of BMD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.11005/jbm.2019.26.1.51

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The results of this meta-analysis reinforce previous reports that levothyroxine treatment-induced subclinical hyperthyroidism affects bone mineral density reduction in postmenopausal women.

    “The results of our meta-analysis reinforce the previous reports that levothyroxine treatment-induced subclinical hyperthyroidism affects BMD reduction in postmenopausal women (16,17,34) for various causes other than DTC were mixed, and the degree of TSH suppression varied considerably.”

    From Effect of TSH Suppression Therapy on Bone Mineral Density in Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis (2021) · cites this paper as [34]

    The Results (Postmenopausal women) report lower hip and spine BMD with TSH suppression therapy, and the Discussion identifies postmenopausal women with differentiated thyroid cancer receiving that therapy as a risk group for bone loss. The paper limits its analysis to patients with differentiated thyroid cancer and says the finding is not conclusive; it does not establish a causal effect of levothyroxine-induced subclinical hyperthyroidism in postmenopausal women generally. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • The cytotoxic effect of PDT is caused by three components: light of a specific wavelength, photosensitizer, and molecular oxygen.

    “The cytotoxic effect is caused by 3 components: light of a specific wavelength, photosensitizer (PS) and molecular oxygen.[28,30,31]”

    From Photodynamic Therapy for Thyroid Cancer (2025) · cites this paper as [31]

    The Introduction and Methods describe a meta-analysis of TSH suppression therapy and bone mineral density in differentiated thyroid cancer. Searches of our copy for photodynamic therapy, photosensitizer, molecular oxygen, and light wavelength found no passage addressing the claimed components of PDT cytotoxicity. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Yoon, B.-H., Lee, Y., Oh, H. J., Kim, S. H., & Lee, Y.-K.
Affiliations
  • Inje University Seoul Paik Hospital (KR)
  • Seoul National University (KR)
  • National Cancer Center (KR)
Corresponding author
Lee, Young-Kyun
Venue
Journal of Bone Metabolism
Published
2019
Volume
26
Issue
1
Pages
51
ISSN
  • 2287-6375 (ISSN-L)
  • 2287-7029
OpenAlex
W2922377130
Cited by
46
References
57
Citations by year
2026: 2 · 2025: 9 · 2024: 4 · 2023: 5 · 2022: 9 · 2021: 7 · 2020: 7 · 2019: 3
FWCI
1.24
Type
journal article
Language
en
Open access
Locations
  • Journal of Bone Metabolism (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
Korea Health Industry Development Institute (HI18C0284)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
Keywords
bone mineral density, differentiated thyroid cancer, subclinical hyperthyroidism, postmenopausal women, bone loss, femoral neck, lumbar spine, total hip

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review